LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 39.41 | 27.76 | 159 | 3105 | 0.0512 | 0.2923 | MN20160318_Q01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 39.41 | 27.76 | 3344 | 3105 | 1.0767 | 1.0218 | MN20160318_Q01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 41.11 | 27.76 | 2087 | 3331 | 0.6264 | 0.8691 | MN20160318_Q01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 41.11 | 27.76 | 3038 | 3331 | 0.9119 | 0.9735 | MN20160318_Q01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 41.11 | 27.76 | 168 | 3331 | 0.0504 | 0.2978 | MN20160318_Q01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 41.11 | 27.76 | 3634 | 3331 | 1.0908 | 1.0253 | MN20160318_Q01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 42.81 | 27.76 | 2227 | 3596 | 0.6193 | 0.8680 | MN20160318_Q01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 42.81 | 27.76 | 3245 | 3596 | 0.9023 | 0.9709 | MN20160318_Q01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 42.81 | 27.76 | 210 | 3596 | 0.0584 | 0.3342 | MN20160318_Q01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 42.81 | 27.76 | 3911 | 3596 | 1.0875 | 1.0241 | MN20160318_Q01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 44.52 | 27.76 | 2477 | 3884 | 0.6377 | 0.8777 | MN20160318_Q01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 44.52 | 27.76 | 3453 | 3884 | 0.8890 | 0.9673 | MN20160318_Q01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 44.52 | 27.76 | 242 | 3884 | 0.0623 | 0.3550 | MN20160318_Q01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 44.52 | 27.76 | 4158 | 3884 | 1.0705 | 1.0192 | MN20160318_Q01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 46.22 | 27.76 | 2713 | 4125 | 0.6577 | 0.8872 | MN20160318_Q01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 46.22 | 27.76 | 3703 | 4125 | 0.8977 | 0.9703 | MN20160318_Q01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 46.22 | 27.76 | 241 | 4125 | 0.0584 | 0.3492 | MN20160318_Q01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 46.22 | 27.76 | 4447 | 4125 | 1.0781 | 1.0209 | MN20160318_Q01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 47.93 | 27.76 | 2680 | 4421 | 0.6061 | 0.8677 | MN20160318_Q01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 47.93 | 27.76 | 3942 | 4421 | 0.8916 | 0.9689 | MN20160318_Q01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 47.93 | 27.76 | 300 | 4421 | 0.0679 | 0.3846 | MN20160318_Q01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 47.93 | 27.76 | 4866 | 4421 | 1.1005 | 1.0264 | MN20160318_Q01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 49.63 | 27.76 | 2747 | 4818 | 0.5702 | 0.8545 | MN20160318_Q01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 49.63 | 27.76 | 4155 | 4818 | 0.8624 | 0.9606 | MN20160318_Q01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 49.63 | 27.76 | 375 | 4818 | 0.0778 | 0.4190 | MN20160318_Q01 | F13 |